/
Company Overview We are a global medical device company focused on helping patients recover and live life to the fullest by relieving pain and addressing musculoskeletal challenges through a diverse portfolio of high-quality, innovative, and clinically-proven solutions. We manage our business through two reporting segments, U.S. and International, which accounted for 88% and 12%, respectively, …
Operating margin is thin at 9.50%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 0.9% YoY. The question is whether this is cyclical or a structural shift.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$576M
▼ -0.9% YoY
Net Income (TTM)
$28M
▲ +162.9% YoY
Op. Margin
9.98%
▲ +12.2pp YoY
ROIC
9.08%
▲ +10.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$101M
▲ +90.8% YoY
Op. Cash Flow (TTM)
$103M
▲ +92.5% YoY
Net Debt
$253M
Cash & Equiv.
$36M
5Y CAGR: +12.1%
5Y CAGR: +5.5%
Continue Research